Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SHE: 002399)

Shenzhen Hepalink Pharmaceutical Group Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 6, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019
Market Capitalization	12,856	15,345	17,090	22,787	23,671	24,333
Market Cap Growth	-24.37%	-10.21%	-25.00%	-3.74%	-2.72%	-15.36%
Enterprise Value	14,860	19,083	19,992	24,281	25,891	29,113
Last Close Price	9.77	11.73	12.74	16.91	16.87	18.98
PE Ratio	-	-21.97	25.71	103.07	22.29	22.34
PS Ratio	2.57	2.82	2.39	3.58	4.44	5.26
PB Ratio	1.18	1.28	1.38	1.98	2.03	3.26
P/FCF Ratio	7.79	-328.85	-17.46	-113.66	-135.10	-41.26
P/OCF Ratio	5.14	38.53	-22.59	-3437.26	634.89	-106.91
EV/Sales Ratio	2.67	3.50	2.79	3.81	4.86	6.30
EV/EBITDA Ratio	47.15	223.24	15.71	22.00	20.11	29.04
EV/EBIT Ratio	-393.35	-80.14	20.02	29.13	25.54	38.98
EV/FCF Ratio	8.08	-408.97	-20.42	-121.11	-147.77	-49.37
Debt / Equity Ratio	0.38	0.46	0.52	0.49	0.48	0.84
Debt / EBITDA Ratio	14.58	46.80	4.95	4.98	4.28	6.28
Debt / FCF Ratio	2.50	-119.22	-6.60	-28.20	-32.22	-10.68
Asset Turnover	0.28	0.27	0.36	0.33	0.31	0.32
Inventory Turnover	0.65	0.67	0.84	1.11	1.19	1.46
Quick Ratio	0.97	0.73	0.93	1.19	1.52	0.62
Current Ratio	2.39	2.13	2.22	2.25	2.53	1.21
Return on Equity (ROE)	-2.12%	-6.58%	5.98%	2.01%	10.66%	15.30%
Return on Assets (ROA)	-0.11%	-0.74%	3.13%	2.73%	3.70%	3.24%
Return on Capital (ROIC)	-0.13%	-0.82%	3.46%	3.02%	4.07%	3.76%
Earnings Yield	-1.69%	-5.10%	4.26%	1.06%	4.33%	4.35%
FCF Yield	12.83%	-0.30%	-5.73%	-0.88%	-0.74%	-2.42%
Dividend Yield	0.00%	-	0.79%	0.21%	0.89%	0.95%
Payout Ratio	0.00%	-	34.51%	171.31%	43.69%	32.33%
Buyback Yield / Dilution	0.01%	0.05%	-0.05%	-8.42%	-8.51%	0.01%
Total Shareholder Return	0.01%	0.05%	0.73%	-8.22%	-7.62%	0.96%

Source: S&P Capital IQ. Standard template. Financial Sources.